垂体细胞瘤2例并文献复习

doi:10.19854/j.cnki.1008-2425.2024.01.0010

摘要/Abstract

摘要： 目的探讨垂体细胞瘤的临床表现、影像学表现、病理及治疗方案。方法回顾分析我科2019年1月至2023年10月的2例垂体细胞瘤的临床资料、影像学表现、病理及治疗方案,并复习相关文献。结果 2例垂体细胞瘤患者,男女各1例,主要症状有头痛、视力下降,头颅磁共振表现为鞍内、鞍上的等T1、等/稍低T2信号,增强后明显强化的实质性病灶。分别予以显微镜下经鼻蝶入路鞍区病变切除术和神经内镜下经鼻蝶入路鞍区病变切除术。术后病理为垂体细胞瘤(WHO I级),术后均未行放疗治疗。两个病例随访4年、3个月未见复发。结论垂体细胞瘤罕见,容易误诊,肿瘤血供丰富,手术全切是治疗的主要方式。

关键词: 垂体细胞瘤, 诊断, 治疗

Abstract: Objective To investigate the clinical and imaging manifestations,pathology and treatment of pituicytoma. Methods The clinical data,imaging findings,pathology and treatment of 2 patients who were diagnosed as pituicytoma in our hospital from January 2019 to October 2023 were retrospectively analyzed,and the relevant literature was reviewed. Results There were 2 patients of pituicytoma,1 male and 1 female.The main symptoms include headache and vision decreased,and the head magnetic resonance imaging showed iso-intense on T1 weighted imaging and hypo- or iso-intense on T2 weighted imaging in and above the sellar region,substantial lesions were increased signal intensity after enhancement.Transnasal sphenoid approach under microscope and neuroendoscope were performed respectively.The postoperative pathology was pituicytoma (WHO Grade I),which was not treated with radiotherapy.Two cases were followed up for 4 years and 3 months without recurrence. Conclusion Pituicytoma is rare and easily misdiagnosed,the blood supply of tumor tissue is affluent,total surgical resection is the main way of treatment.

Key words: Pituicytoma, Diagnosis, Treatment.

中图分类号:

R736.4

李政, 牛朝诗, 梅加明, 王宣之, 陈鹏. 垂体细胞瘤2例并文献复习[J]. 立体定向和功能性神经外科杂志, 2024, 37(1): 48-53.

Li Zheng, Niu Chaoshi, Mei Jiaming, Wang xuanzhi, ChenPeng. Pituicytoma:2 cases and literature review[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2024, 37(1): 48-53.

参考文献

[1] Viaene AN,Lee EB,Rosenbaum JN,et al.Histologic,immunohistochemical,and molecular features of pituicytomas and atypical pituicytomas[J].Acta neuropathologica communications,2019,7(1):1~11.
[2] Brat DJ,Scheithauer BW,Staugaitis SM,et al.Pituicytoma:a distinctive low-grade glioma of the neurohypophysis[J].The American journal of surgical pathology,2000,24(3):362~368.
[3] Brat DJ,Scheithauer BW,Fuller GN,et al.Newly codified glial neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System:angiocentric glioma,pilomyxoid astrocytoma and pituicytoma[J].Brain pathology,2007,17(3):319~324.
[4] Iglesias P,Guerrero-Pérez F,Villabona C,et al.Adenohypophyseal hyperfunction syndromes and posterior pituitary tumors:prevalence,clinical characteristics,and pathophysiological mechanisms[J].Endocrine,2020,70(1):15~23.
[5] Liss L,Kahn EA.Pituicytoma.Tumor of the sella turcica:a clinicopathological study[J].Journal of Neurosurgery,1958,15(5):481~488.
[6] Louis D N,Perry A,Reifenberger G,et al.The 2016 World Health Organization classification of tumors of the central nervous system:a summary[J].Acta neuropathologica,2016,131(6):803~820.
[7] Brandão RACS,Braga MHV,de Souza AA,et al.Pituicytoma[J].Surgical Neurology International,2010,1(1):79.
[8] Schmalisch K,Schittenhelm J,Ebner F H,et al.Pituicytoma in a patient with Cushing's disease:case report and review of the literature[J].Pituitary,2012,15(1):10~16.
[9] Mete O,Lopes MB.Overview of the 2017 WHO classification of pituitary tumors[J].Endocrine Pathology,2017,28(3):228~243.
[10] Asa SL,Mete O,Perry A,et al.Overview of the 2022 WHO classification of pituitary tumors[J].Endocrine pathology,2022,33(1):6~26.
[11] Yoshimoto T,Takahashi-Fujigasaki J,Inoshita N,et al.TTF-1-positive oncocytic sellar tumor with follicle formation/ependymal differentiation:non-adenomatous tumor capable of two different interpretations as a pituicytoma or a spindle cell oncocytoma[J].Brain Tumor Pathology,2015,32(3):221~227.
[12] Takei H,Goodman JC,Tanaka S,et al.Pituicytoma incidentally found at autopsy[J].Pathology international,2005,55(11):745~749.
[13] Nakasu Y,Nakasu S,Saito A,et al.Pituicytoma-Two Case Reports-[J].Neurologia medico-chirurgica,2006,46(3):152~156.
[14] Chang TW,Lee CY,Jung S M,et al.Correlations between clinical hormone change and pathological features of pituicytoma[J].British Journal of Neurosurgery,2018,32(5):501~508.
[15] Shah B,Lipper MH,Laws ER,et al.Posterior pituitary astrocytoma:a rare tumor of the neurohypophysis:a case report[J].American journal of neuroradiology,2005,26(7):1858~1861.
[16] Al-Salihi MM,Ahmed A,Al-Jebur M S,et al.A rare case of pituicytoma-related hyperprolactinemia due to mass effect on infundibular stalk-Case report[J].International Journal of Surgery Case Reports,2023,107:108348.
[17] Gibbs WN,Monuki ES,Linskey ME,et al.Pituicytoma:diagnostic features on selective carotid angiography and MR imaging[J].American journal of neuroradiology,2006,27(8):1639~1642.
[18] Trifa A,Knafo S,Maatoug A,et al.Surgical management of pituicytomas:a single-center case series[J].Acta Neurologica Belgica,2023,123(3):815~822.
[19] Furtado S V,Ghosal N,Venkatesh P K,et al.Diagnostic and clinical implications of pituicytoma[J].Journal of Clinical Neuroscience,2010,17(7):938~943.
[20] Covington MF,Chin SS,Osborn A G.Pituicytoma,spindle cell oncocytoma,and granular cell tumor:clarification and meta-analysis of the world literature since 1893[J].American journal of neuroradiology,2011,32(11):2067~2072.
[21] Pascual JM,Prieto R,Carrasco R,et al.The 2013 Sixto Obrador Award.A triple-axis topographical model for surgical planning of craniopharyngiomas.Part II:anatomical and neuroradiological evidence to define triple-axis topography and its usefulness in predicting individual surgical risk[J].Neurocirugia (Asturias,Spain),2014,25(5):211~239.
[22] 杨虹,蒋冰,刘骞,等.18例垂体细胞瘤的临床病理特点分析[J].大连医科大学学报,2021,43(3):228~234.
[23] 司海鹏,王剑蓉,章宜芬,等.垂体细胞瘤及其罕见室管膜样亚型的临床病理分析[J].临床与实验病理学杂志,2018,34(3):284~288.
[24] Salge-Arrieta FJ,Carrasco-Moro R,Rodríguez-Berrocal V,et al.Clinical features,diagnosis and therapy of pituicytoma:an update[J].Journal of endocrinological investigation,2019,42:371~384.
[25] Chen B,Fan X,Zhang Z.Pituicytoma:report of three cases and a systematic literature review[J].Clinical Neurology and Neurosurgery,2021,205:106650.
[26] Kuga D,Toda M,Ozawa H,et al.Endoscopic endonasal approach combined with a simultaneous transcranial approach for giant pituitary tumors[J].World neurosurgery,2019,121:173~179.
[27] Gondim JA,Almeida JPC,Albuquerque LAF,et al.Giant pituitary adenomas:surgical outcomes of 50 cases operated on by the endonasal endoscopic approach[J].World neurosurgery,2014,82(1-2):e281~e290.
[28] Kuo CH,Yen YS,Wu JC,et al.Primary endoscopic transnasal transsphenoidal surgery for giant pituitary adenoma[J].World neurosurgery,2016,91:121~128.
[29] Wei LD,Li C,Li D,et al.Treatment and prognostic factors of pituicytoma:a single-center experience and comprehensive literature review[J].Pituitary,2021,24(5):754~767.